These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34610596)

  • 41. Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych].
    Dutkowska A; Konieczna A; Breska-Kruszewska J; Sendrakowska M; Kowalska I; Rachoń D
    Endokrynol Pol; 2019; 70(2):198-212. PubMed ID: 31039273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition.
    Barrea L; Muscogiuri G; Pugliese G; de Alteriis G; Colao A; Savastano S
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome.
    Chatzis P; Tziomalos K; Pratilas GC; Makris V; Sotiriadis A; Dinas K
    Folia Med (Plovdiv); 2018 Dec; 60(4):512-520. PubMed ID: 31188761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management.
    Farshchi H; Rane A; Love A; Kennedy RL
    J Obstet Gynaecol; 2007 Nov; 27(8):762-73. PubMed ID: 18097891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obesity and the polycystic ovary syndrome.
    Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
    Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of changes in dietary habits in polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Reprod Biomed Online; 2004 Apr; 8(4):431-9. PubMed ID: 15149567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin-lowering agents in the management of polycystic ovary syndrome.
    De Leo V; la Marca A; Petraglia F
    Endocr Rev; 2003 Oct; 24(5):633-67. PubMed ID: 14570747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic Syndrome: Polycystic Ovary Syndrome.
    Mortada R; Williams T
    FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
    Moran LJ; Pasquali R; Teede HJ; Hoeger KM; Norman RJ
    Fertil Steril; 2009 Dec; 92(6):1966-82. PubMed ID: 19062007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference?
    Liepa GU; Sengupta A; Karsies D
    Nutr Clin Pract; 2008 Feb; 23(1):63-71. PubMed ID: 18203965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Khatlani K; Njike V; Costales VC
    Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
    Mehrabani HH; Salehpour S; Amiri Z; Farahani SJ; Meyer BJ; Tahbaz F
    J Am Coll Nutr; 2012 Apr; 31(2):117-25. PubMed ID: 22855917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
    Jiskoot G; Benneheij SH; Beerthuizen A; de Niet JE; de Klerk C; Timman R; Busschbach JJ; Laven JS
    Reprod Health; 2017 Mar; 14(1):34. PubMed ID: 28264692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome.
    Moran L; Norman RJ
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):719-36. PubMed ID: 15380143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.
    Turner-McGrievy G; Davidson CR; Billings DL
    Hum Fertil (Camb); 2015 Mar; 18(1):16-21. PubMed ID: 24921163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin resistance in patients with polycystic ovary syndrome.
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effectiveness of high intensity intermittent training on metabolic, reproductive and mental health in women with polycystic ovary syndrome: study protocol for the iHIT- randomised controlled trial.
    Hiam D; Patten R; Gibson-Helm M; Moreno-Asso A; McIlvenna L; Levinger I; Harrison C; Moran LJ; Joham A; Parker A; Shorakae S; Simar D; Stepto N
    Trials; 2019 Apr; 20(1):221. PubMed ID: 30992038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.